L. Waqatakirewa

发表

Prevalence of symptoms of childhood asthma, allergic rhinoconjunctivitis and eczema in the Pacific: The International Study of Asthma and Allergies in Childhood (ISAAC)

I. Annesi-Maesano, N. Pearce, S. Foliaki, 2007, Allergy.

Prevalence of HPV infection and other risk factors in a Fijian population

S. Franceschi, N. Pearce, C. Meijer, 2014, Infectious Agents and Cancer.

Prospective Surveillance of Invasive Group A Streptococcal Disease, Fiji, 2005–2007

J. Carapetis, M. Batzloff, M. Good, 2009, Emerging infectious diseases.

Serum 25-hydroxyvitamin D concentration of Indigenous-Fijian and Fijian-Indian women.

T. Green, L. Waqatakirewa, A. N. Khan, 2010, Asia Pacific journal of clinical nutrition.

Social Cognitive Theory Constructs That Predict Betel Nut Chewing Among Secondary Students in the Solomon Islands

H. Danawi, L. Waqatakirewa, Manoj Sharma, 2022 .

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.

Y. Cheung, J. Carapetis, E. Mulholland, 2011, Vaccine.

Pneumococcal Nasopharyngeal Carriage following Reduced Doses of a 7-Valent Pneumococcal Conjugate Vaccine and a 23-Valent Pneumococcal Polysaccharide Vaccine Booster

Y. Cheung, J. Carapetis, E. Mulholland, 2010, Clinical and Vaccine Immunology.

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy.

Y. Cheung, J. Carapetis, E. Mulholland, 2010, Vaccine.

High prevalence of rheumatic heart disease by clinical and echocardiographic screening among children in Fiji.

J. Carapetis, E. Mulholland, N. Wilson, 2009, The Journal of heart valve disease.

Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months.

Y. Cheung, J. Carapetis, E. Mulholland, 2011, Vaccine.

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine.

Y. Cheung, J. Carapetis, E. Mulholland, 2009, Vaccine.

Invasive Pneumococcal Disease in Fiji: Clinical Syndromes, Epidemiology, and the Potential Impact of Pneumococcal Conjugate Vaccine

J. Carapetis, E. Mulholland, L. Tikoduadua, 2010, The Pediatric infectious disease journal.

Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005–2007

J. Carapetis, E. Mulholland, M. Batzloff, 2009, The Medical journal of Australia.

High Burden of Impetigo and Scabies in a Tropical Country

J. Carapetis, E. Mulholland, M. Batzloff, 2009, PLoS neglected tropical diseases.

Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.

Y. Cheung, J. Carapetis, E. Mulholland, 2010, Vaccine.

Chest X-ray-confirmed pneumonia in children in Fiji.

E. Mulholland, J. Carapetis, L. Tikoduadua, 2005, Bulletin of the World Health Organization.

Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005–2008

M. Batzloff, A. Steer, A. Jenney, 2016 .

PHD Vol 11 No 2. Hawaii

N. Pearce, S. Foliaki, T. Fakakovikaetau, 2008 .

Risk factors for symptoms of childhood asthma, allergic rhinoconjunctivitis and eczema in the Pacific: an ISAAC Phase III study.

J. Douwes, I. Annesi-Maesano, N. Pearce, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Prospective Surveillance of Invasive Group A Streptococcal Disease, Fiji, 2005–2007

M. Batzloff, A. Jenney, J. Kado, 2009, Emerging infectious diseases.

Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005–2007

J. Carapetis, E. Mulholland, M. Batzloff, 2009, The Medical journal of Australia.